IGFBP7 and chronic kidney disease: For instance, elevated cystatin C can guide clinicians in initiating earlier interventions to prevent rapid progression [15], while markers such as TIMP-2 and IGFBP7 help identify patients who might benefit from targeted preventive strategies against acute kidney injury (AKI) and subsequent CKD progression [29].